Search

Author/Creator Lehmann, Lucine

1. Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin. Issue 6 (8th April 2019)

Authors:
Vilsbøll, Tina; Blevins, Thomas C.; Jodar, Esteban; Poulter, Neil; Tentolouris, Nikolaos; Ross Agner, Bue F.; Lehmann, Lucine; Leiter, Lawrence A.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 6(2019)
Page Start:
1506
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used. Issue 11 (10th July 2017)

Authors:
Norwood, Paul; Chen, Roger; Jaeckel, Elmar; Lingvay, Ildiko; Jarlov, Henrik; Lehmann, Lucine; Heller, Simon
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 11(2017)
Page Start:
1562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial. Issue 1 (February 2017)

Authors:
Linjawi, Sultan; Bode, Bruce; Chaykin, Louis; Courrèges, Jean-Pierre; Handelsman, Yehuda; Lehmann, Lucine; Mishra, Abhishek; Simpson, Richard
Journal:
Diabetes therapy
Issue:
Volume 8:Issue 1(2017)
Page Start:
101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗